Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes
Hypertrophic cardiomyopathy (HCM) is a myocardial disease characterized by left ventricular hypertrophy not solely explained by abnormal loading conditions. Despite its rare prevalence in pediatric age, HCM carries a relevant risk of mortality and morbidity in both infants and children. Pediatric HC...
Main Authors: | Emanuele Monda, Marta Rubino, Michele Lioncino, Francesco Di Fraia, Roberta Pacileo, Federica Verrillo, Annapaola Cirillo, Martina Caiazza, Adelaide Fusco, Augusto Esposito, Fabio Fimiani, Giuseppe Palmiero, Giuseppe Pacileo, Paolo Calabrò, Maria Giovanna Russo, Giuseppe Limongelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Pediatrics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fped.2021.632293/full |
Similar Items
-
Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes
by: Emanuele Monda, et al.
Published: (2022-02-01) -
Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy
by: Martina Caiazza, et al.
Published: (2020-08-01) -
Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies
by: Emanuele Monda, et al.
Published: (2020-09-01) -
Left Ventricular Non-Compaction in Children: Aetiology and Diagnostic Criteria
by: Emanuele Monda, et al.
Published: (2024-01-01) -
MicroRNAs: From Junk RNA to Life Regulators and Their Role in Cardiovascular Disease
by: Federica Amodio, et al.
Published: (2021-11-01)